Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

CRAI vs ACCL: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CRAI Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 9–1 Matrix Metrics)

CRAI Overall Winner 6-Pillar Tally: CRAI 4 – 1 ACCL (1 Tie) Matrix Metrics: CRAI 9 – 1 ACCL

As of Nov 16, 2026, CRA International, Inc. (CRAI) is the stronger overall head-to-head candidate over ACCL (ACCL) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CRAI carries a Unified Composite Score of 45.3/100 (HOLD) at $210.50 (21.9x Forward P/E, 10.4% operating margin), whereas ACCL carries 63.4/100 (BUY) at $2.36 (N/M Forward P/E, 4.5% operating margin).

  • Composite vs. Pillar Nuance: While ACCL currently prints a higher short-term Unified Composite Score (63.4/100 BUY vs. CRAI 45.3/100 HOLD), CRAI captures the overall institutional head-to-head verdict (9–1 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (10.4% vs. 4.5% operating margin) and revenue trajectory (+15.6% vs. +11.3% YoY).
  • Technical & Structure Timing Caution: CRAI trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 72.2); meanwhile ACCL is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CRAI vs ACCL
CRAI NASDAQ Head-to-Head Winner
CRA International, Inc.
Services-Legal Services
$210.50
+2.53% 1D
Market Cap $1.3B
TTM Revenue $824M
Forward P/E 21.9x
Beta / 30D Vol -0.40β · 42% Vol
Unified Composite Score
45.3 / 100 HOLD
Tech 25.0 Fund 34.0 Flow 50.0 Mom 25.9
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (6.1% over 20 days), RSI 72
RSI-14: 72.2 · SMA20: $197.27 · SMA50: $180.37
ACCL US Equity
ACCL
Institutional Equity
$2.36
-0.84% 1D
Market Cap $33.5M
TTM Revenue $5.2M
Forward P/E N/M
Beta / 30D Vol -0.20β · 60% Vol
Unified Composite Score
63.4 / 100 BUY
Tech 68.0 Fund 58.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -4.9%), weak momentum, RSI 39
RSI-14: 39.2 · SMA20: $2.54 · SMA50: $2.65

6-Pillar Scorecard Institutional Category Breakdown (CRAI 4 – 1 ACCL)

Columns: Metric · CRAI · ACCL
1. Valuation Multiples CRAI
Forward P/E 21.9x N/M
Trailing P/E 25.0x 120.0x
PEG Ratio 1.31x N/M
EV / Revenue 1.5x 6.5x
2. Growth & Scale CRAI
Revenue Growth (YoY) +15.6% +11.3%
Earnings Growth (YoY) +26.9% -62.5%
TTM Revenue (USD) $824M $5.2M
Market Cap $1.3B $33.5M
3. Profitability & Quality CRAI
Gross Margin 29.0% 42.4%
Operating Margin 10.4% 4.5%
Net Profit Margin 6.3% 5.5%
Return on Equity (ROE) 26.2% 7.0%
4. Balance Sheet & Cash Flow CRAI
Cash Generation (TTM) $100M EBITDA $245,425 EBITDA
Cash Flow Margin 12.1% EBITDA Mgn 4.7% EBITDA Mgn
Net Cash / Leverage $30.78 Book/Sh · 26.2% ROE $0.43 Book/Sh · 7.0% ROE
Dividend Yield 1.14% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 28.9% (2nd %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Markdown
6. R&D & Supply-Chain Moat ACCL
OpEx & R&D Intensity 18.6% of Rev ($153M) 37.9% of Rev ($2.0M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Consulting Services Operator Consulting Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CRAI (9) vs ACCL (1)
Institutional Metric CRAI ACCL Criterion Row Edge
Market Capitalization
Scale
$1.3B $33.5M Larger Scale CRAI
Trailing P/E Ratio
Valuation
25.0x 120.0x Lower Multiple CRAI
Forward P/E Ratio
Valuation
21.9x N/M Lower Multiple CRAI
Revenue Growth (YoY)
Growth
+15.6% +11.3% Higher Growth CRAI
Operating Margin (TTM)
Profitability
10.4% 4.5% Higher Margin CRAI
Net Profit Margin
Profitability
6.3% 5.5% Higher Margin CRAI
Return on Equity (ROE)
Capital Efficiency
26.2% 7.0% Higher ROE CRAI
52-Week Range Position
Momentum
82% ($132–$227) 30% ($1–$5) Stronger Trend CRAI
Beta / 30D Volatility
Risk Regime
-0.40β · 42% Vol -0.20β · 60% Vol Lower Realized Risk CRAI
Unified Institutional Score
Composite Signal
45.3 / 100 (HOLD) 63.4 / 100 (BUY) Higher Composite ACCL
Trailing 12M Revenue (USD)
Operating Scale
$824M $5.2M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
29.0% 42.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.31x PEG · 1.5x EV/Rev N/M PEG · 6.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$100M EBITDA ($30.78 Book/Sh · 26.2% ROE) $245,425 EBITDA ($0.43 Book/Sh · 7.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CRAI +32.16 pp
CRAI: +19.9% · ACCL: -12.26%
3M Horizon CRAI +41.95 pp
CRAI: +25.05% · ACCL: -16.9%
6M Horizon ACCL +9.04 pp
CRAI: +51.51% · ACCL: +60.55%
1Y Horizon CRAI +59.7 pp
CRAI: +16.03% · ACCL: -43.67%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CRAI vs ACCL. Trailing 12-month operating profitability (CRAI 10.4% vs ACCL 4.5%) and valuation multiples (CRAI 21.9x vs ACCL N/M Forward P/E) are benchmarked directly in Pillar 4 below.

CRAI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$824M
Gross Margin29.0%
Op. Margin10.4%
ROE / Fwd P/E26.2% · 21.9x
ACCL ADR TTM Benchmark FX-Normalized USD
TTM Revenue$5.2M
Gross Margin42.4%
Op. Margin4.5%
ROE / Fwd P/E7.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CRAI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 28.9%
IV Percentile 2nd %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CRAI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ACCL UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ACCL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CRAI Moat Profile Scale & Operating Efficiency Moat
Consulting Services Operator
Competes within the Consulting Services value chain with $1.3B market capitalization and 10.4% operating margin.
OpEx & R&D Reinvestment 18.6% of Rev ($153M)
90D Engineering Disclosures 0 Published
ACCL Moat Profile Cyclical / Execution-Driven Positioning
Consulting Services Operator
Competes within the Consulting Services value chain with $33.5M market capitalization and 4.5% operating margin.
OpEx & R&D Reinvestment 37.9% of Rev ($2.0M)
90D Engineering Disclosures 0 Published

Investor FAQ CRAI vs ACCL Key Questions & Quantitative Answers

As of Nov 16, 2026, CRA International, Inc. (CRAI) is the stronger overall head-to-head candidate over ACCL (ACCL) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CRAI carries a Unified Composite Score of 45.3/100 (HOLD) at $210.50 (21.9x Forward P/E, 10.4% operating margin), whereas ACCL carries 63.4/100 (BUY) at $2.36 (N/M Forward P/E, 4.5% operating margin). Composite vs. Pillar Nuance: While ACCL currently prints a higher short-term Unified Composite Score (63.4/100 BUY vs. CRAI 45.3/100 HOLD), CRAI captures the overall institutional head-to-head verdict (9–1 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (10.4% vs. 4.5% operating margin) and revenue trajectory (+15.6% vs. +11.3% YoY). Technical & Structure Timing Caution: CRAI trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 72.2); meanwhile ACCL is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CRAI leads the Growth & Scale pillar: CRAI posts +15.6% YoY revenue growth and +26.9% YoY earnings growth on $824M TTM revenue (29.0% gross margin, 10.4% operating margin), compared with ACCL at +11.3% YoY revenue growth and -62.5% YoY earnings growth on $5.2M TTM revenue (42.4% gross margin, 4.5% operating margin). On trailing 12-month operating scale, CRAI generates $824M in USD-normalized revenue versus $5.2M for ACCL. In operating R&D and SG&A reinvestment, CRAI deploys 18.6% of Rev ($153M) (0 90-day corporate R&D disclosures) versus 37.9% of Rev ($2.0M) (0 disclosures) for ACCL.

CRAI screens cheaper on headline valuation multiples. CRAI trades at 21.9x Forward P/E, 25.0x Trailing P/E, 1.31x PEG, and 1.5x EV/Revenue (12.1% EBITDA margin), whereas ACCL trades at N/M Forward P/E, 120.0x Trailing P/E, N/M PEG, and 6.5x EV/Revenue (4.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CRAI (26.2% ROE) versus ACCL (7.0% ROE) capital efficiency.

In options market volatility and institutional positioning, CRAI carries 28.9% implied volatility (2nd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.40β · 42% Vol realized risk). By comparison, ACCL carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.20β · 60% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.